Correction to: Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes (Nature Communications, (2024), 15, 1, (7880), 10.1038/s41467-024-52025-x)

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-52025-x, published online 09 September 2024 In this article, the affiliation details were incorrect for the following authors: Timothy Chang, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Yi Zhao, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Yuk Yee Leung, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA Pavel P Kuksa, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA Vishakha Patil, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Wan-Ping Lee, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA Amanda B. Kuzma, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Otto Valladres, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Laura B. Cantwell, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Hui Wang, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA Ashvin Ravi, Department of Neuroscience, Department of Genetics & Genomic Sciences, Nash Family Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, New York, NY, USA. Ruth H. Walker, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, and Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA Melissa J. Nirenberg, Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, and Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, NY, USA Giovanni Coppola, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Günter U. Höglinger, Department of Neurology, Ludwig-Maximilians-Universität Hospital, Ludwig-Maximilians-Universität (LMU) Munichen, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Germany and the German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Ulrich Müller, Institute of Human Genetics, Justus-Liebig University Giessen, 35392 Giessen, Germany Lawrence I. Golbe Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA CurePSP, Inc., New York, NY, USA Huw R. Morris, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK John Hardy, University College London Queen Square Institute of Neurology and Dementia Research Institute, London, UK Tamas Revesz, Queen Square Brain Bank for Neurological Disorders, Queen Square Institute of Neurology, University College London, London, UK Tom T. Warner Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UK Queen Square Brain Bank for Neurological Disorders, University College London, London, UK Zane Jaunmuktane, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UK Queen Square Brain Bank for Neurological Disorders, University College London, London, UK Kin Y. Mok, University College London Queen Square Institute of Neurology and Dementia Research Institute, London, UK Rosa Rademakers, VIB Center for Molecular Neurology, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA Dennis W. Dickson, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA Owen A Ross, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA Li-San Wang, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, PA, USA Gerard Schellenberg, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Daniel H. Geschwind, Program in Neurogenetics, Center for Autism Research and Treatment Semel Institute for Neuroscience and Human Behavior, Department of Neurology, Department of Human Genetics, Institute for Precision Health, David Geffen School of Medicine, University of California, Los Angeles CA, USA Adam Naj, Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA The PSP genetics study group Franziska Hopfner German Center for Neurodegenerative Diseases (DZNE), Munich; Department of Neurology, LMU Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany Günter U. Höglinger, Department of Neurology, Ludwig-Maximilians-Universität Hospital, Ludwig-Maximilians-Universität (LMU) Munichen, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, Germany and the German Center for Neurodegenerative Diseases (DZNE), Munich, Germany Sigrun Roeber, German Center for Neurodegenerative Diseases (DZNE), Center for Neuropathology and Prion Research, LMU Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany Jochen Herms, German Center for Neurodegenerative Diseases (DZNE), Center for Neuropathology and Prion Research, LMU Hospital, Ludwig-Maximilians-Universität (LMU), Munich, Germany Claire Troakes, MRC Centre for Neurodegeneration Research, King’s College London, London, UK Ellen Gelpi, Movement Disorders Unit, Neurology Department and Neurological Tissue Bank and Neurology Department, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain Yaroslau Compta, Movement Disorders Unit, Neurology Department and Neurological Tissue Bank and Neurology Department, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain John C. van Swieten, Department of Neurology and Netherlands Brain Bank, Erasmus Medical Centre, Rotterdam, The Netherlands Alex Rajput, Division of Neurology, Royal University Hospital, University of Saskatchewan, Canada Fairlie Hinton, Australian Brain Bank Network in collaboration with the Victorian Brain Bank Network, Australia Justo García de Yebenes, Department of Neurology, Hospital Ramón y Cajal, Madrid, Spain The original article has been corrected.